As of the latest Form 4 filed Jun 10, 2026.
What Chemed Corp insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 32 most recent filings for CHE.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-10 | 2026-06-09 | LINDELL ANDREA R Director | SSale | −1.35K | $447.33 | $603K | No | Form 4 ↗ |
| 2026-05-29 | 2026-05-29 | WALSH GEORGE J III Director | SSale | −500.00 | $437.83 | $219K | No | Form 4 ↗ |
| 2026-05-19 | 2026-05-18 | WALSH GEORGE J III Director | AAward | +386.00 | $440.77 | $170K | No | Form 4 ↗ |
| 2026-05-19 | 2026-05-18 | Mount John Meredith Jr. Director | AAward | +386.00 | $440.77 | $170K | No | Form 4 ↗ |
| 2026-05-19 | 2026-05-18 | McCarthy Eileen P Director | AAward | +386.00 | $440.77 | $170K | No | Form 4 ↗ |
| 2026-05-19 | 2026-05-18 | LINDELL ANDREA R Director | AAward | +386.00 | $440.77 | $170K | No | Form 4 ↗ |
| 2026-05-19 | 2026-05-18 | Heaney Christopher J Director | AAward | +386.00 | $440.77 | $170K | No | Form 4 ↗ |
| 2026-05-19 | 2026-05-18 | GRACE PATRICK P Director | AAward | +386.00 | $440.77 | $170K | No | Form 4 ↗ |
| 2026-05-19 | 2026-05-18 | DeLyons Ron Director | AAward | +386.00 | $440.77 | $170K | No | Form 4 ↗ |
| 2026-05-08 | 2026-05-08 | GRACE PATRICK P Director | SSale | −60.00 | $425.78 | $25.5K | No | Form 4 ↗ |
| 2026-05-04 | 2026-05-01 | MCNAMARA KEVIN J president and CEO | SSale | −2.00K | $421.13 | $842K | No | Form 4 ↗ |
| 2026-03-30 | 2026-03-27 | MCNAMARA KEVIN J president and CEO | SSale | −1.50K | $369.37 | $554K | No | Form 4 ↗ |
| 2026-03-13 | 2026-03-12 | MCNAMARA KEVIN J president and CEO | SSale | −2.00K | $403.18 | $806K | No | Form 4 ↗ |
| 2026-02-17 | 2026-02-13 | LEE SPENCER S executive vice president | FTax | −154.00 | $469.56 | $72.3K | No | Form 4 ↗ |
| 2026-02-17 | 2026-02-13 | LEE SPENCER S, executive vice president | MExercise | +0.00 | $469.56 | $0.00 | No | Form 4 ↗ |
| 2026-02-17 | 2026-02-13 | LEE SPENCER S, executive vice president | MExercise | +499.00 | $469.56 | $234K | No | Form 4 ↗ |
| 2026-02-17 | 2026-02-13 | HUTTON THOMAS C vice president | FTax | −72.00 | $469.56 | $33.8K | No | Form 4 ↗ |
| 2026-02-17 | 2026-02-13 | HUTTON THOMAS C, vice president | MExercise | +0.00 | $469.56 | $0.00 | No | Form 4 ↗ |
| 2026-02-17 | 2026-02-13 | HUTTON THOMAS C, vice president | MExercise | +199.00 | $469.56 | $93.4K | No | Form 4 ↗ |
| 2026-02-17 | 2026-02-13 | Wherley Joel L CEO - Vitas Healthcare | FTax | −80.00 | $469.56 | $37.6K | No | Form 4 ↗ |
| 2026-02-17 | 2026-02-13 | Wherley Joel L, CEO - Vitas Healthcare | MExercise | +0.00 | $469.56 | $0.00 | No | Form 4 ↗ |
| 2026-02-17 | 2026-02-13 | Wherley Joel L, CEO - Vitas Healthcare | MExercise | +273.00 | $469.56 | $128K | No | Form 4 ↗ |
| 2026-02-17 | 2026-02-13 | Witzeman Michael D VP & Chief Financial Officer | FTax | −120.00 | $469.56 | $56.3K | No | Form 4 ↗ |
| 2026-02-17 | 2026-02-13 | Witzeman Michael D, VP & Chief Financial Officer | MExercise | +0.00 | $469.56 | $0.00 | No | Form 4 ↗ |
| 2026-02-17 | 2026-02-13 | Witzeman Michael D, VP & Chief Financial Officer | MExercise | +413.00 | $469.56 | $194K | No | Form 4 ↗ |
| 2026-02-17 | 2026-02-13 | MCNAMARA KEVIN J president and CEO | FTax | −1.19K | $469.56 | $560K | No | Form 4 ↗ |
| 2026-02-17 | 2026-02-13 | MCNAMARA KEVIN J, president and CEO | MExercise | +0.00 | $469.56 | $0.00 | No | Form 4 ↗ |
| 2026-02-17 | 2026-02-13 | MCNAMARA KEVIN J, president and CEO | MExercise | +2.71K | $469.56 | $1.27M | No | Form 4 ↗ |
| 2026-02-17 | 2026-02-13 | Judkins Brian C VP and Chief Legal Officer | FTax | −102.00 | $469.56 | $47.9K | No | Form 4 ↗ |
| 2026-02-17 | 2026-02-13 | Judkins Brian C, VP and Chief Legal Officer | MExercise | +0.00 | $469.56 | $0.00 | No | Form 4 ↗ |
| 2026-02-17 | 2026-02-13 | Judkins Brian C, VP and Chief Legal Officer | MExercise | +351.00 | $469.56 | $165K | No | Form 4 ↗ |
| 2025-12-29 | 2025-12-26 | LINDELL ANDREA R Director | GGift | −463.00 | $0.00 | $0.00 | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also CHE’s full analysis or the market-wide insider trading feed. The tabs above jump to CHE’s other SEC data.
Source: SEC Form 4 filings for CHE, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.